Metabolism and pharmacokinetics of the anti-HIV-1-specific inhibitor [1-[2′,5′-Bis-O-(tert-butyldimethylsilyl)-β-d-ribofuranosyl]-3-N-methyl-thymine]-3′-spiro-5″-(4″-amino-1″,2″-oxathiole--Reference-Cited by-同舟云学术

Metabolism and pharmacokinetics of the anti-HIV-1-specific inhibitor [1-[2′,5′-Bis-O-(tert-butyldimethylsilyl)-β-d-ribofuranosyl]-3-N-methyl-thymine]-3′-spiro-5″-(4″-amino-1″,2″-oxathiole-

Published:1993-07 Issue:1 Volume:46 Page:69-77
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Balzarini Jan,Naesens Lieve,Bohman Christina,Pérez-Pérez Maria-Jésus,San-Félix Ana,Camarasa Maria-Jose,de Clercq Erik

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference21 articles.

1. Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivative;Baba;Biochem Biophys Res Commun,1989

2. Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives;Pauwels;Nature,1990

3. Inhibition of HIV-1 replication by a nonnucleoside reverse transcriptase inhibitor;Merluzzi;Science,1990

4. Pyridinone derivatives: specific human immunodeficiency virus type 1 reverse transcriptase inhibitors with antiviral activity;Goldman,1991

5. Nonnucleoside reverse transcriptase inhibitors that potently and specifically block human immunodeficiency virus type 1 replication;Romero,1991

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Recent Overview of 1,2,3-Triazole-Containing Hybrids as Novel Antifungal Agents: Focusing on Synthesis, Mechanism of Action, and Structure-Activity Relationship (SAR);Journal of Chemistry;2022-01-06

2. Efficient conversion of tetrapeptide-based TSAO prodrugs to the parent drug by dipeptidyl-peptidase IV (DPPIV/CD26);Antiviral Research;2007-11

3. Design and Discovery of a Novel Dipeptidyl-peptidase IV (CD26)-Based Prodrug Approach;Journal of Medicinal Chemistry;2006-08-01

4. TSAO Derivatives, Inhibitors of HIV-1 Reverse Transcriptase Dimerization: Recent Progress;Current Pharmaceutical Design;2006-05-01

5. TSAO Derivatives the First Non-Peptide Inhibitors of HIV-1 RT Dimerization;Antiviral Chemistry and Chemotherapy;2005-06